Evaluation of Advanced US Tools in Assessing Allograft Complications
NCT ID: NCT04423458
Last Updated: 2023-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2022-01-04
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Study of Contrast-Enhanced Ultrasound of Transplanted Kidney
NCT01883583
Kidney Transplant Volumetry
NCT03855085
Renal Allograft : Evaluation of Parenchymal Fibrosis by Elastography
NCT01234363
Contrast-Enhanced Ultrasound for Kidney Transplant
NCT02911714
Protocol-Specified Modification of Immunosuppression Directed to Protocol Biopsy in Kidney Transplantation
NCT02294097
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim one will concentrate on the 3D US in assessing artery stenosis (TRAS) compared to the gold standard.
Aim two focuses on will concentrate on Ultrasound elastography in assessing renal stiffness.
Aim three will compare US colour modes such as PD, CD and MFI to assess renal perfusion in three groups.
Duration: 18 Months; participants will have a patient information sheet; once they are happy to participate, consent will be obtained.
Study data will be entered into a database encrypted and stored in the department. Only the study principal investigator (PI) will know the study database password.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transplanted kidney
No intervention is required. Routine Doppler assessment + 3D scan + Shear wave elastography + MicrFlow Imaging will be immediately recorded afterwards
3D imaging
The study will focus on the accuracy of ultrasound technology in assessing renal transplants.
The entire assessment should not take more than 25 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3D imaging
The study will focus on the accuracy of ultrasound technology in assessing renal transplants.
The entire assessment should not take more than 25 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Tx patients.
* Gender.
Exclusion Criteria
* Patients \< 18 years.
* Pregnant women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohammed Aslam, PhD
Role: STUDY_DIRECTOR
Academic Supervisor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imperial College London
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
848 -20HH6053
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.